John Yan
69Patents
26h-index
26Co-inventors
88Inventor score
Filing activity: Jun 5, 1989 → Oct 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6240616A | Method of manufacturing a medicated porous metal prosthesis | Emerging Cross-Sectional Technologies | 553 | Expired |
| US5843172A | Porous medicated stent | Human Necessities | 525 | Expired |
| US6174329A | Protective coating for a stent with intermediate radiopaque coating | Human Necessities | 329 | Expired |
| US6723120B2 | Medicated porous metal prosthesis | Emerging Cross-Sectional Technologies | 256 | Expired |
| US6471980B2 | Intravascular delivery of mycophenolic acid | Human Necessities | 207 | Expired |
| US7077859B2 | Apparatus and methods for variably controlled substance delivery from implanted prostheses | Human Necessities | 159 | Expired |
| US6245076A | Temperature activated adhesive for releasably attaching stents to balloons | Human Necessities | 153 | Expired |
| US6066156A | Temperature activated adhesive for releasably attaching stents to balloons | Human Necessities | 143 | Expired |
| US6602282B1 | Flexible stent structure | Human Necessities | 138 | Expired |
| US7083642B2 | Delivery of therapeutic capable agents | Human Necessities | 132 | Expired |
| US6569180B1 | Catheter having exchangeable balloon | Human Necessities | 126 | Expired |
| US4960425A | Textured surface frosthesis implants | Human Necessities | 107 | Expired |
| US6648911B1 | Method and device for the treatment of vulnerable tissue site | Human Necessities | 97 | Expired |
| US7131986B2 | Catheter having exchangeable balloon | Human Necessities | 76 | Expired |
| US5022942A | Method of making textured surface prosthesis implants | Emerging Cross-Sectional Technologies | 76 | Expired |
| US6287277A | Balloon formation by vacuum deposition | Performing Operations; Transporting | 63 | Expired |
| US5911452A | Apparatus and method for mounting a stent onto a catheter | Emerging Cross-Sectional Technologies | 56 | Expired |
| US7077860B2 | Method of reducing or eliminating thrombus formation | Emerging Cross-Sectional Technologies | 54 | Expired |
| US8007529B2 | Medicated porous metal prosthesis | Emerging Cross-Sectional Technologies | 43 | Active |
| US6776792B1 | Coated endovascular stent | Emerging Cross-Sectional Technologies | 40 | Expired |
| US6605114B1 | Heparin delivery method | Emerging Cross-Sectional Technologies | 37 | Expired |
| US8182890B2 | Biodegradable endoprostheses and methods for their fabrication | Emerging Cross-Sectional Technologies | 36 | Active |
| US8323760B2 | Biodegradable endoprostheses and methods for their fabrication | Emerging Cross-Sectional Technologies | 34 | Active |
| US8636792B2 | Biodegradable endoprostheses and methods for their fabrication | Performing Operations; Transporting | 30 | Active |
| US8814930B2 | Biodegradable endoprosthesis and methods for their fabrication | Performing Operations; Transporting | 30 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.